Consumer health care companies are traditionally great recession plays, because no matter what happens in the economy, people still need their medicine.
For more than 100 years, Johnson & Johnson (NYSE: JNJ) has supplied the world with what it needs to ameliorate its ailments.
In addition to marquee consumer brands such as Band-Aid and Tylenol, Johnson & Johnson provides the world with a myriad of prescription drugs, medical devices and medical treatments that keep us all healthy.
The healing power -- and the earnings power -- of Johnson & Johnson's products has contributed to the well-being of both consumers and investors for a very long time.
And while shareholders may justifiably feel ill about the stock over the last several months, the company's long-term growth prospects will likely serve as a veritable love potion for investors in the years to come.
Take a look at all ten stocks to fall in love with again.
Jim Woods is a Senior Editor for OptionsZone.com.
Closing Bell: Dubai sends jitters throughout the market (S, BBY)
Heinz looking good after the second quarter?
Why isn't Bank of America updating its shareholders on CEO situation?
